Prevalence of lymph node metastasis in primary mucinous carcinoma of the ovary.

Schmeler KM, Tao X, Frumovitz M, Deavers MT, Sun CC, Sood AK, Brown J, Gershenson DM, Ramirez PT

Sunitinib malate in the treatment of recurrent or persistent uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study.

Hensley ML, Sill MW, Scribner DR Jr, Brown J, Debernardo RL, Hartenbach EM, McCourt CK, Bosscher JR, Gehrig PA

Anti-angiogenesis therapy with bevacizumab for patients with ovarian granulosa cell tumors.

Tao X, Sood AK, Deavers MT, Schmeler KM, Nick AM, Coleman RL, Milojevic L, Gershenson DM, Brown J

Patterns of metastasis in sex cord-stromal tumors of the ovary: can routine staging lymphadenectomy be omitted?

Brown J, Sood AK, Deavers MT, Milojevic L, Gershenson DM

In vitro evaluation of the effects of gefitinib on the cytotoxic activity of selected anticancer agents in a panel of human endometrial cancer cell lines.

Gaikwad A, Wolf JK, Brown J, Ramondetta LM, Smith JA

Postoperative small bowel obstruction associated with use of hemostatic agents.

Hobday CD, Milam MR, Milam RA, Euscher E, Brown J

Combined large cell neuroendocrine carcinoma and papillary serous carcinoma of the endometrium with pagetoid spread.

Posligua L, Malpica A, Liu J, Brown J, Deavers MT

Robotic radical parametrectomy and pelvic lymphadenectomy in patients with invasive cervical cancer.

Ramirez PT, Schmeler KM, Wolf JK, Brown J, Soliman PT

In vitro evaluation of the growth inhibition and apoptosis effect of mifepristone (RU486) in human Ishikawa and HEC1A endometrial cancer cell lines.

Navo MA, Smith JA, Gaikwad A, Burke T, Brown J, Ramondetta LM

In vitro evaluation of the effects of gefitinib on the modulation of cytotoxic activity of selected anticancer agents in a panel of human ovarian cancer cell lines.

Smith JA, Gaikwad A, Yu J, Wolf JK, Brown J, Ramondetta LM, Stewart CF